Differential regulation of proinflammatory cytokine expression by mitogen-activated protein kinases in macrophages in response to intestinal parasite infection

Infection and Immunity

Volumn 82, Issue 11, 2014, Pages 4789-4801

  Lim, Mei Xing ^a,b   Png, Chin Wen ^a,b   Tay, Crispina Yan Bing ^a,b   Teo, Joshua Ding Wei ^a   Jiao, Huipeng ^a,b   Lehming, Norbert ^a   Tan, Kevin Shyong Wei ^a   Zhang, Yongliang ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; MITOGEN ACTIVATED PROTEIN KINASE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLASTOCYSTOSIS; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RESPONSE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HOST PATHOGEN INTERACTION; INTESTINE CELL; INTESTINE EPITHELIUM; MACROPHAGE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BLASTOCYSTIS; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; TISSUE CULTURE TECHNIQUE;

ANIMALS; BLASTOCYSTIS; BLASTOCYSTIS INFECTIONS; CELL LINE; CYTOKINES; GENE EXPRESSION REGULATION; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; TISSUE CULTURE TECHNIQUES;

EID: 84907958777     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02279-14     Document Type: Article

References (72)

1. Strober W, Fuss IJ, Blumberg RS. 2002. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20:495-549. http://dx.doi.org/10.1146/annurev.immunol.20.100301.064816.
2. Kaser A, Zeissig S, Blumberg RS. 2010. Inflammatory bowel disease. Annu. Rev. Immunol. 28:573-621. http://dx.doi.org/10.1146/annurev-immunol-030409-101225.
3. Tan KS, Mirza H, Teo JD, Wu B, Macary PA. 2010. Current views on the clinical relevance of Blastocystis spp. Curr. Infect. Dis. Rep. 12:28-35. http://dx.doi.org/10.1007/s11908-009-0073-8.
4. Tan KS. 2008. New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin. Microbiol. Rev. 21:639-665. http://dx.doi.org/10.1128/CMR.00022-08.
5. Clark CG. 1997. Extensive genetic diversity in Blastocystis hominis. Mol. Biochem. Parasitol. 87:79-83. http://dx.doi.org/10.1016/S0166-6851(97)00046-7.
6. Alfellani MA, Taner-Mulla D, Jacob AS, Imeede CA, Yoshikawa H, Stensvold CR, Clark CG. 2013. Genetic diversity of blastocystis in livestock and zoo animals. Protist 164:497-509. http://dx.doi.org/10.1016/j.protis.2013.05.003.
7. Dominguez-Marquez MV, Guna R, Munoz C, Gomez-Munoz MT, Borras R. 2009. High prevalence of subtype 4 among isolates of Blastocystis hominis from symptomatic patients of a health district of Valencia (Spain). Parasitol. Res. 105:949-955. http://dx.doi.org/10.1007/s00436-009-1485-y.
8. Hailemariam G, Kassu A, Abebe G, Abate E, Damte D, Mekonnen E, Ota F. 2004. Intestinal parasitic infections in HIV/AIDS and HIV seronegative individuals in a teaching hospital, Ethiopia. Jpn. J. Infect. Dis. 57:41-43.
9. Cirioni O, Giacometti A, Drenaggi D, Ancarani F, Scalise G. 1999. Prevalence and clinical relevance of Blastocystis hominis in diverse patient cohorts. Eur. J. Epidemiol. 15:389-393.
10. Tasova Y, Sahin B, Koltas S, Paydas S. 2000. Clinical significance and frequency of Blastocystis hominis in Turkish patients with hematological malignancy. Acta Med. Okayama 54:133-136.
11. Yakoob J, Jafri W, Jafri N, Islam M, Asim Beg M. 2004. In vitro susceptibility of Blastocystis hominis isolated from patients with irritable bowel syndrome. Br. J. Biomed. Sci. 61:75-77.
12. Stark D, van Hal S, Marriott D, Ellis J, Harkness J. 2007. Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. Int. J. Parasitol. 37:11-20. http://dx.doi.org/10.1016/j.ijpara.2006.09.009.
13. Dogruman-Al F, Kustimur S, Yoshikawa H, Tuncer C, Simsek Z, Tanyuksel M, Araz E, Boorom K. 2009. Blastocystis subtypes in irritable bowel syndrome and inflammatory bowel disease in Ankara, Turkey. Mem. Inst. Oswaldo Cruz 104:724-727. http://dx.doi.org/10.1590/S0074-02762009000500011.
14. Dogruman-Al F, Simsek Z, Boorom K, Ekici E, Sahin M, Tuncer C, Kustimur S, Altinbas A. 2010. Comparison of methods for detection of Blastocystis infection in routinely submitted stool samples, and also in IBS/IBD patients in Ankara, Turkey. PLoS One 5:e15484. http://dx.doi.org/10.1371/journal.pone.0015484.
15. Jimenez-Gonzalez DE, Martinez-Flores WA, Reyes-Gordillo J, Ramirez-Miranda ME, Arroyo-Escalante S, Romero-Valdovinos M, Stark D, Souza-Saldivar V, Martinez-Hernandez F, Flisser A, Olivo-Diaz A, Maravilla P. 2012. Blastocystis infection is associated with irritable bowel syndrome in a Mexican patient population. Parasitol. Res. 110:1269-1275. http://dx.doi.org/10.1007/s00436-011-2626-7.
16. Zuckerman MJ, Watts MT, Ho H, Meriano FV. 1994. Blastocystis hominis infection and intestinal injury. Am. J. Med. Sci. 308:96-101. http://dx.doi.org/10.1097/00000441-199408000-00006.
17. Puthia MK, Sio SW, Lu J, Tan KS. 2006. Blastocystis ratti induces contact-independent apoptosis, F-actin rearrangement, and barrier function disruption in IEC-6 cells. Infect. Immun. 74:4114-4123. http://dx.doi.org/10.1128/IAI.00328-06.
18. Long HY, Handschack A, Konig W, Ambrosch A. 2001. Blastocystis hominis modulates immune responses and cytokine release in colonic epithelial cells. Parasitol. Res. 87:1029-1030.
19. Puthia MK, Lu J, Tan KS. 2008. Blastocystis ratti contains cysteine proteases that mediate interleukin-8 response from human intestinal epithelial cells in an NF-kappaB-dependent manner. Eukaryot. Cell 7:435-443. http://dx.doi.org/10.1128/EC.00371-07.
20. Moe KT, Singh M, Howe J, Ho LC, Tan SW, Chen XQ, Ng GC, Yap EH. 1997. Experimental Blastocystis hominis infection in laboratory mice. Parasitol. Res. 83:319-325. http://dx.doi.org/10.1007/s004360050256.
21. Iguchi A, Yoshikawa H, Yamada M, Kimata I, Arizono N. 2009. Expression of interferon gamma and proinflammatory cytokines in the cecal mucosa of rats experimentally infected with Blastocystis sp. strain RN94-9. Parasitol. Res. 105:135-140. http://dx.doi.org/10.1007/s00436-009-1373-5.
22. Wu LY, Fu RJ, Lu ZC, Tang LL, Zhang F, Liu DY. 2012. Expressions and significance of IL-17 and IL-23 in intestinal mucosa of mice infected with Blastocystis hominis. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 24:676-680.
23. Mirza H, Tan KS. 2009. Blastocystis exhibits inter- and intra-subtype variation in cysteine protease activity. Parasitol. Res. 104:355-361. http://dx.doi.org/10.1007/s00436-008-1203-1.
24. Mirza H, Wu Z, Kidwai F, Tan KS. 2011. A metronidazole-resistant isolate of Blastocystis spp. is susceptible to nitric oxide and downregulates intestinal epithelial inducible nitric oxide synthase by a novel parasite survival mechanism. Infect. Immun. 79:5019-5026. http://dx.doi.org/10.1128/IAI.05632-11.
25. Olivo-Diaz A, Romero-Valdovinos M, Gudino-Ramirez A, Reyes-Gordillo J, Jimenez-Gonzalez DE, Ramirez-Miranda ME, Martinez-Flores WA, Martinez-Hernandez F, Flisser A, Maravilla P. 2012. Findings related to IL-8 and IL-10 gene polymorphisms in a Mexican patient population with irritable bowel syndrome infected with Blastocystis. Parasitol. Res. 111:487-491. http://dx.doi.org/10.1007/s00436-012-2830-0.
26. Keyse SM. 2000. Protein phosphatases and the regulation of mitogenactivated protein kinase signalling. Curr. Opin. Cell Biol. 12:186-192. http://dx.doi.org/10.1016/S0955-0674(99)00075-7.
27. Ryang YS, Chang JH, Park JY. 2004. Involvement of MAP kinases in apoptosis of macrophage treated with Trichomonas vaginalis. Yonsei Med. J. 45:751-754.
28. Zhang YL, Dong C. 2005. MAP kinases in immune responses. Cell Mol. Immunol. 2:20-27.
29. Imajo M, Tsuchiya Y, Nishida E. 2006. Regulatory mechanisms and functions of MAP kinase signaling pathways. IUBMB Life 58:312-317. http://dx.doi.org/10.1080/15216540600746393.
30. Lee HY, Hyung S, Lee NY, Yong TS, Han SH, Park SJ. 2012. Excretory-secretory products of Giardia lamblia induce interleukin-8 production in human colonic cells via activation of p38, ERK1/2, NFkappaB and AP-1. Parasite Immunol. 34:183-198. http://dx.doi.org/10.1111/j.1365-3024.2012.01354.x.
31. Ropert C, Almeida IC, Closel M, Travassos LR, Ferguson MA, Cohen P, Gazzinelli RT. 2001. Requirement of mitogen-activated protein kinases and I kappa B phosphorylation for induction of proinflammatory cytokines synthesis by macrophages indicates functional similarity of receptors triggered by glycosylphosphatidylinositol anchors from parasitic protozoa and bacterial lipopolysaccharide. J. Immunol. 166:3423-3431. http://dx.doi.org/10.4049/jimmunol.166.5.3423.
32. Kim JY, Ahn MH, Song HO, Choi JH, Ryu JS, Min DY, Cho MH. 2006. Involvement of MAPK activation in chemokine or COX-2 productions by Toxoplasma gondii. Korean J. Parasitol. 44:197-207. http://dx.doi.org/10.3347/kjp.2006.44.3.197.
33. Rawal S, Majumdar S, Vohra H. 2005. Activation of MAPK kinase pathway by Gal/GalNAc adherence lectin of E. histolytica: gateway to host response. Mol. Cell. Biochem. 268:93-101. http://dx.doi.org/10.1007/s11010-005-3698-4.
34. Ivory CP, Prystajecky M, Jobin C, Chadee K. 2008. Toll-like receptor 9-dependent macrophage activation by Entamoeba histolytica DNA. Infect. Immun. 76:289-297. http://dx.doi.org/10.1128/IAI.01217-07.
35. Chen XQ, Singh M, Ho LC, Moe KT, Tan SW, Yap EH. 1997. A survey of Blastocystis sp. in rodents. Lab. Anim. Sci. 47:91-94.
36. Stensvold CR, Suresh GK, Tan KS, Thompson RC, Traub RJ, Viscogliosi E, Yoshikawa H, Clark CG. 2007. Terminology for Blastocystis subtypes-a consensus. Trends Parasitol. 23:93-96. http://dx.doi.org/10.1016/j.pt.2007.01.004.
37. Stadnyk AW. 2002. Intestinal epithelial cells as a source of inflammatory cytokines and chemokines. Can. J. Gastroenterol. 16:241-246.
38. Murphy K, Travers P, Walport M. 2008. Janeway's immunobiology. Garland Science, New York, NY.
39. Dong C, Davis RJ, Flavell RA. 2002. MAP kinases in the immune response. Annu. Rev. Immunol. 20:55-72. http://dx.doi.org/10.1146/annurev.immunol.20.091301.131133.
40. McKerrow JH, Caffrey C, Kelly B, Loke P, Sajid M. 2006. Proteases in parasitic diseases. Annu. Rev. Pathol. 1:497-536. http://dx.doi.org/10.1146/annurev.pathol.1.110304.100151.
41. Puthia MK, Vaithilingam A, Lu J, Tan KS. 2005. Degradation of human secretory immunoglobulin A by Blastocystis. Parasitol. Res. 97:386-389. http://dx.doi.org/10.1007/s00436-005-1461-0.
42. Boorom KF, Smith H, Nimri L, Viscogliosi E, Spanakos G, Parkar U, Li LH, Zhou XN, Ok UZ, Leelayoova S, Jones MS. 2008. Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection. Parasit. Vectors 1:40. http://dx.doi.org/10.1186/1756-3305-1-40.
43. Scanlan PD. 2012. Blastocystis: past pitfalls and future perspectives. Trends Parasitol. 28:327-334. http://dx.doi.org/10.1016/j.pt.2012.05.001.
44. Kasper LH, Buzoni-Gatel D. 2001. Ups and downs of mucosal cellular immunity against protozoan parasites. Infect. Immun. 69:1-8. http://dx.doi.org/10.1128/IAI.69.1.1-8.2001.
45. Hermann GE, Rogers RC. 2008. TNFalpha: a trigger of autonomic dysfunction. Neuroscientist 14:53-67. http://dx.doi.org/10.1177/1073858407305725.
46. Zwingenberger K, Harms G, Pedrosa C, Pessoa MC, Sandkamp B, Scheibenbogen C, Andreesen R. 1991. Generation of cytokines in human visceral leishmaniasis: dissociation of endogenous TNF-alpha and IL-1 beta production. Immunobiology 183:125-132. http://dx.doi.org/10.1016/S0171-2985(11)80192-0.
47. Camargo MM, Almeida IC, Pereira ME, Ferguson MA, Travassos LR, Gazzinelli RT. 1997. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes initiate the synthesis of proinflammatory cytokines by macrophages. J. Immunol. 158:5890-5901.
48. Sharma M, Vohra H, Bhasin D. 2005. Enhanced pro-inflammatory chemokine/cytokine response triggered by pathogenic Entamoeba histolytica: basis of invasive disease. Parasitology 131:783-796. http://dx.doi.org/10.1017/S0031182005008541.
49. Han IH, Goo SY, Park SJ, Hwang SJ, Kim YS, Yang MS, Ahn MH, Ryu JS. 2009. Proinflammatory cytokine and nitric oxide production by human macrophages stimulated with Trichomonas vaginalis. Korean J. Parasitol. 47:205-212. http://dx.doi.org/10.3347/kjp.2009.47.3.205.
50. Cader MZ, Kaser A. 2013. Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation. Gut 62:1653-1664. http://dx.doi.org/10.1136/gutjnl-2012-303955.
51. Mirza H, Wu Z, Teo JD, Tan KS. 2012. Statin pleiotropy prevents rho kinase-mediated intestinal epithelial barrier compromise induced by Blastocystis cysteine proteases. Cell. Microbiol. 14:1474-1484. http://dx.doi.org/10.1111/j.1462-5822.2012.01814.x.
52. Kamada N, Hisamatsu T, Okamoto S, Chinen H, Kobayashi T, Sato T, Sakuraba A, Kitazume MT, Sugita A, Koganei K, Akagawa KS, Hibi T. 2008. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-gamma axis. J. Clin. Invest. 118:2269-2280. http://dx.doi.org/10.1172/JCI34610.
53. Sheth K, Friel J, Nolan B, Bankey P. 2001. Inhibition of p38 mitogen activated protein kinase increases lipopolysaccharide induced inhibition of apoptosis in neutrophils by activating extracellular signal-regulated kinase. Surgery 130:242-248. http://dx.doi.org/10.1067/msy.2001.115902.
54. Jijon HB, Panenka WJ, Madsen KL, Parsons HG. 2002. MAP kinases contribute to IL-8 secretion by intestinal epithelial cells via a posttranscriptional mechanism. Am. J. Physiol. Cell Physiol. 283:C31-C41. http://dx.doi.org/10.1152/ajpcell.00113.2001.
55. Scanlan PD, Stensvold CR. 2013. Blastocystis: getting to grips with our guileful guest. Trends Parasitol. 29:523-529. http://dx.doi.org/10.1016/j.pt.2013.08.006.
56. Denoeud F, Roussel M, Noel B, Wawrzyniak I, Da Silva C, Diogon M, Viscogliosi E, Brochier-Armanet C, Couloux A, Poulain J, Segurens B, Anthouard V, Texier C, Blot N, Poirier P, Ng GC, Tan KS, Artiguenave F, Jaillon O, Aury JM, Delbac F, Wincker P, Vivares CP, El Alaoui H. 2011. Genome sequence of the stramenopile Blastocystis, a human anaerobic parasite. Genome Biol. 12:R29. http://dx.doi.org/10.1186/gb-2011-12-3-r29.
57. Sio SW, Puthia MK, Lee AS, Lu J, Tan KS. 2006. Protease activity of Blastocystis hominis. Parasitol. Res. 99:126-130. http://dx.doi.org/10.1007/s00436-006-0131-1.
58. Arastu-Kapur S, Ponder EL, Fonovic UP, Yeoh S, Yuan F, Fonovic M, Grainger M, Phillips CI, Powers JC, Bogyo M. 2008. Identification of proteases that regulate erythrocyte rupture by the malaria parasite Plasmodium falciparum. Nat. Chem. Biol. 4:203-213. http://dx.doi.org/10.1038/nchembio.70.
59. de Matos Guedes HL, Pinheiro RO, Chaves SP, De-Simone SG, Rossi-Bergmann B. 2010. Serine proteases of Leishmania amazonensis as immunomodulatory and disease-aggravating components of the crude LaAg vaccine. Vaccine 28:5491-5496. http://dx.doi.org/10.1016/j.vaccine.2010.04.109.
60. de Almeida Nogueira NP, Morgado-Diaz JA, Menna-Barreto RF, Paes MC, da Silva-Lopez RE. 2013. Effects of a marine serine protease inhibitor on viability and morphology of Trypanosoma cruzi, the agent of Chagas disease. Acta Trop. 128:27-35. http://dx.doi.org/10.1016/j.actatropica.2013.05.013.
61. Yakoob J, Jafri W, Beg MA, Abbas Z, Naz S, Islam M, Khan R. 2010. Irritable bowel syndrome: is it associated with genotypes of Blastocystis hominis. Parasitol. Res. 106:1033-1038. http://dx.doi.org/10.1007/s00436-010-1761-x.
62. Gecse K, Roka R, Ferrier L, Leveque M, Eutamene H, Cartier C, Ait-Belgnaoui A, Rosztoczy A, Izbeki F, Fioramonti J, Wittmann T, Bueno L. 2008. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity. Gut 57:591-599. http://dx.doi.org/10.1136/gut.2007.140210.
63. Colognato R, Slupsky JR, Jendrach M, Burysek L, Syrovets T, Simmet T. 2003. Differential expression and regulation of protease-activated receptors in human peripheral monocytes and monocyte-derived antigenpresenting cells. Blood 102:2645-2652. http://dx.doi.org/10.1182/blood-2002-08-2497.
64. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. 2001. Proteinase-activated receptors. Pharmacol. Rev. 53:245-282.
65. Kida Y, Inoue H, Shimizu T, Kuwano K. 2007. Serratia marcescens serralysin induces inflammatory responses through protease-activated receptor 2. Infect. Immun. 75:164-174. http://dx.doi.org/10.1128/IAI.01239-06.
66. Hansen KK, Sherman PM, Cellars L, Andrade-Gordon P, Pan Z, Baruch A, Wallace JL, Hollenberg MD, Vergnolle N. 2005. A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis. Proc. Natl. Acad. Sci. U. S. A. 102:8363-8368. http://dx.doi.org/10.1073/pnas.0409535102.
67. Rothmeier AS, Ruf W. 2012. Protease-activated receptor 2 signaling in inflammation. Semin. Immunopathol. 34:133-149. http://dx.doi.org/10.1007/s00281-011-0289-1.
68. Mirza H, Teo JD, Upcroft J, Tan KS. 2011. A rapid, high-throughput viability assay for Blastocystis spp. reveals metronidazole resistance and extensive subtype-dependent variations in drug susceptibilities. Antimicrob. Agents Chemother. 55:637-648. http://dx.doi.org/10.1128/AAC.00900-10.
69. Stensvold CR, Nielsen HV, Molbak K, Smith HV. 2009. Pursuing the clinical significance of Blastocystis-diagnostic limitations. Trends Parasitol. 25:23-29. http://dx.doi.org/10.1016/j.pt.2008.09.010
70. Poirier P, Wawrzyniak I, Vivares CP, Delbac F, El Alaoui H. 2012. New Insights into Blastocystis spp.: a potential link with irritable bowel syndrome. PLoS Pathog. 8:e1002545. http://dx.doi.org/10.1371/journal.ppat.1002545.
71. Stensvold CR, Christiansen DB, Olsen KE, Nielsen HV. 2011. Blastocystis sp. subtype 4 is common in Danish Blastocystis-positive patients presenting with acute diarrhea. Am. J. Trop. Med. Hyg. 84:883-885. http://dx.doi.org/10.4269/ajtmh.2011.11-0005.
72. Lee IL, Tan TC, Tan PC, Nanthiney DR, Biraj MK, Surendra KM, Suresh KG. 2012. Predominance of Blastocystis sp. subtype 4 in rural communities, Nepal. Parasitol. Res. 110:1553-1562. http://dx.doi.org/10.1007/s00436-011-2665-0.